Lv1
30 积分 2025-09-05 加入
Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial
4个月前
已完结
Adjuvant capecitabine in early-stage triple-negative breast cancer? Yes, but for whom?
4个月前
已完结
Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial
4个月前
已完结
CD8-Guided Immunochemotherapy Improves Pathological Complete Response Rates in High Tumor Burden Triple-Negative Breast Cancer
5个月前
已完结
MTClin: Integrating MammaTyper® to Predict Neoadjuvant Therapy Response in HER2+ Breast Cancer
6个月前
已完结
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
7个月前
已完结
Machine learning and SHAP value interpretation for predicting cardiovascular disease risk in patients with diabetes using dietary antioxidants
皖公网安备34019202002308
